Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Healthcare Medical Devices
Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers... see more

Recent & Breaking News (TSXV:EVMT)

Salona Global Announces the Debut of the Biodex SpaceTek Knee(TM), a Revolutionary Portable Isokinetic Knee Dynamometer Medical Device Developed in NASA Collaboration

GlobeNewswire November 16, 2023

Salona Global Completes Turn Around Plan with Profitable Third Quarter, Posting Record Results with 18.5% Quarterly Organic Revenue Growth and 29% Quarterly Gross Profit Growth; Generates $749,425 in Adjusted EBITDA for the Quarter

GlobeNewswire November 15, 2023

Salona Global Showcases Biodex Products at Medica Trade Fair in Düsseldorf, Germany; Expanding Access to International Markets

GlobeNewswire November 14, 2023

Salona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish Market

GlobeNewswire October 25, 2023

Salona Global Announces Plans to Change Name to Evome Medical Technologies Inc.; Confirms Positive Adjusted EBITDA and Net Profit for Q3 2023; Appoints New CFO

GlobeNewswire October 19, 2023

Salona Global Announces Expansion of Bank Line

GlobeNewswire September 18, 2023

Salona Global Posts Second Quarter Results and Provides Update on Turn Around Plan

GlobeNewswire August 14, 2023

Salona Global Extends Biodex Acquisition Debt Duration to July 2025

GlobeNewswire August 8, 2023

Salona Global Announces Debt Reduction, Provides Update on Cost Cuts and Debt Restructuring; Appoints Mike Seckler as permanent Chief Executive Officer

GlobeNewswire July 25, 2023

Salona Global Appoints Michael Seckler, Medical Sales & Marketing Senior Executive, as Interim CEO; Adjusts Management Team with a Focus on Cash Flow

GlobeNewswire June 14, 2023

Salona Global Announces Appointment of Lana Newishy to Board of Directors as Vice Chair and Enters into Financial Consulting Agreement

GlobeNewswire May 25, 2023

Salona Global Closes Acquisition of Arrowhead Medical, Provides Update on Biodex Integration; Posts First Quarter Results with Positive Adjusted EBITDA, 23% Annual Revenue Growth and 27% Growth in Annual Gross Profits, Improved Quarter-over-Quarter Gross Profit from 33.1% to 38%

GlobeNewswire May 16, 2023

Salona Global to Host First Quarter 2023 Conference Call on May 16, 2023

GlobeNewswire May 11, 2023

Salona Global Closes the Biodex Acquisition, Adding $26 Million in Projected Annual Revenue; Posts Audited Year-End Financial Statements with 167% Revenue Growth

GlobeNewswire April 3, 2023

Salona Global Plans to Close the Acquisition of the Physical Medicine Business of Biodex on April 3, 2023; Engages Maxim Group LLC as Exclusive Investment Banking Advisor for US Capital Markets

GlobeNewswire March 16, 2023

Gap Partners, Inc. Files Early Warning Report in Respect of Securities of Salona Global Medical Device Corporation

Newsfile March 13, 2023

Salona Global Provides Acquisitions Update, Highlights from U.S. Roadshow Presentation

GlobeNewswire February 9, 2023

Salona Global Announces Third Quarter Results, Posts 211% Year-Over-Year Revenue Growth, 231% in Gross Margin Growth, Improved Gross Margin to 33%; Shifts Focus to Higher Margin Revenue Lines

GlobeNewswire January 17, 2023

Salona Global to Host Third Quarter 2022 Conference Call on January 17, 2023

GlobeNewswire January 12, 2023

Salona Global Focuses on US Capital Markets for 2023; Changes Fiscal Year End to December 31, 2022 to Prepare for US Listing; Withdraws Canadian Debenture Offering

GlobeNewswire December 15, 2022